Trial Information
Inclusion Criteria:
- Recurrent transitional cell carcinoma of urinary bladder post endoscopic resection
- PSA Prior synergo therapy application<10
- Normal rectal examination
- Patients willing to sign informed consent according
Exclusion Criteria:
- History of prostate cancer
- Previous history of TCC stage T2 or higher
- Invasive tu of bladder
- Prior pelvic radiotherapy or systemic chemotherapy
- Active prostatitis
- Active tuberculosis
Type of Study:
Observational
Study Design:
Time Perspective: Prospective
Principal Investigator
PEREZ DORON, M.D.
Investigator Role:
Principal Investigator
Investigator Affiliation:
HAEMEK MEDICAL CENTER, UROLOGY DEPARTMENT
Authority:
Israel: Ethics Commission
Study ID:
0034-07-EMC
NCT ID:
NCT00491296
Start Date:
June 2007
Completion Date:
June 2007
Related Keywords:
- Bladder Cancer
- S/P Transuretral resection of bladder tumor
- Recurrent tumor after BCG Treatment
- Urinary Bladder Neoplasms